Complex regulation of Calbindin-D9k in the mouse placenta and extra-embryonic membrane during mid- and late pregnancy

被引:21
作者
An, BS
Choi, KC
Lee, GS
Leung, PCK
Jeung, EB [1 ]
机构
[1] Chungbuk Natl Univ, Coll Vet Med, Lab Vet Biochem & Mol Biol, Cheongju 361763, Chungbuk, South Korea
[2] Univ British Columbia, BC Res Inst Childrens & Womens Hlth, Dept Obstet & Gynecol, Vancouver, BC V6H 3V5, Canada
[3] Seoul Natl Univ, Xenotransplantat Res Ctr, Seoul, South Korea
关键词
Calbindin-D-9k; mouse placenta; extra-embryonic membrane;
D O I
10.1016/j.mce.2003.11.029
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Calbindin-D-9k (CaBP-9k) is a cytosolic calcium-binding protein mainly expressed in the duodenum, uterus and placenta, however, the role of CaBP-9k in the regulation of fetal growth remains to be elucidated. The present study was performed to investigate the expression pattern and regulation of CaBP-9k by antagonists of steroid hormones related with steroid hormone receptors during mid- and late pregnancy in mouse placenta and extra-embryonic membrane. The expression level of CaBP-9k increased in the placenta, while it decreased in the extra-embryonic membrane during pregnancy. The mRNA expression levels of estrogen receptor alpha (ERalpha) and progesterone receptor (PR) appeared to increase in both placenta and extra-embryonic membrane during pregnancy, suggesting that the ER and PR mRNA and protein expressions of placental CaBP-9k are positively correlated, but expressions of extra-embryonic membrane CaBP-9k are reversely correlated with ERalpha and PR mRNA levels. In addition, the present study indicates that the expressions of CaBP-9k mRNA and protein are differentially up- or down-regulated by antagonists of estrogen (E2) and progesterone (P4) in mouse placenta and extra-embryonic membranes, which suggests that E2 and P4 may be dominant factors in the regulation of the CaBP-9k. In particular, RU486, an antagonist of P4, down-regulated the mRNA and protein levels of placental CaBP-9k, whereas it up-regulated the protein level of extra-embryonic membrane CaBP-9k. In conclusion, we demonstrated that the CaBP-9k is distinctly regulated in the mouse placenta and extra-embryonic membrane, probably via sex steroid hormones (E2 and P4) and their receptors through a complex pathway. Extended studies are needed to verify relevant factors to regulate CaBP-9k gene and to provide further insight into roles of CaBP-9k gene in these tissues for the control of reproductive functions. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 52
页数:14
相关论文
共 47 条
[1]   EXPRESSION OF CALBINDIN-D DECREASES WITH AGE IN INTESTINE AND KIDNEY [J].
ARMBRECHT, HJ ;
BOLTZ, M ;
STRONG, R ;
RICHARDSON, A ;
BRUNS, MEH ;
CHRISTAKOS, S .
ENDOCRINOLOGY, 1989, 125 (06) :2950-2956
[2]   Calcium-binding proteins - Distribution and implication in mammalian placenta [J].
Belkacemi, L ;
Simoneau, L ;
Lafond, J .
ENDOCRINE, 2002, 19 (01) :57-64
[3]   VITAMIN-D-DEPENDENT CALCIUM-BINDING PROTEIN IN RAT UTERUS - DIFFERENTIAL-EFFECTS OF ESTROGEN, TAMOXIFEN, PROGESTERONE, AND PREGNANCY ON ACCUMULATION AND CELLULAR-LOCALIZATION [J].
BRUNS, ME ;
OVERPECK, JG ;
SMITH, GC ;
HIRSCH, GN ;
MILLS, SE ;
BRUNS, DE .
ENDOCRINOLOGY, 1988, 122 (06) :2371-2378
[4]  
BRUNS ME, 1985, ANAT REC, V213, P532
[5]   REGULATION OF CALCIUM-BINDING PROTEIN IN MOUSE PLACENTA AND INTESTINE [J].
BRUNS, MEH ;
WALLSHEIN, V ;
BRUNS, DE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (01) :E47-E52
[6]   The regulation of apoptosis by activin and transforming growth factor-β in early neoplastic and tumorigenic ovarian surface epithelium [J].
Choi, KC ;
Kang, SK ;
Tai, CJ ;
Auersperg, N ;
Leung, PCK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :2125-2135
[7]   Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells [J].
Choi, KC ;
Kang, SK ;
Tai, CJ ;
Auersperg, N ;
Leung, PCK .
ENDOCRINOLOGY, 2001, 142 (06) :2351-2360
[8]   VITAMIN D-DEPENDENT CALCIUM-BINDING PROTEINS - CHEMISTRY, DISTRIBUTION, FUNCTIONAL CONSIDERATIONS, AND MOLECULAR-BIOLOGY [J].
CHRISTAKOS, S ;
GABRIELIDES, C ;
RHOTEN, WB .
ENDOCRINE REVIEWS, 1989, 10 (01) :3-26
[9]   Anti-implantation activity of antiestrogens and mifepristone [J].
Dao, B ;
Vanage, G ;
Marshall, A ;
Bardin, CW ;
Koide, SS .
CONTRACEPTION, 1996, 54 (04) :253-258
[10]  
DARWISH H, 1991, J BIOL CHEM, V266, P551